Medical oncology laboratory (VUmc)

89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC
Miedema, I. H. C., Huisman, M. C., Zwezerijnen, G. J. C., Grempler, R., Pitarch, A. P., Thiele, A., Hesse, R., Elgadi, M., Peltzer, A., Vugts, D. J., van Dongen, G. A. M. S., de Gruijl, T. D., Menke-van der Houven van Oordt, C. W. & Bahce, I., 2023, (E-pub ahead of print) In: European journal of nuclear medicine and molecular imaging.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies
Lameris, R., Ruben, J. M., Iglesias-Guimarais, V., de Jong, M., Veth, M., van de Bovenkamp, F. S., de Weerdt, I., Kater, A. P., Zweegman, S., Horbach, S., Riedl, T., Winograd, B., Roovers, R. C., Adang, A. E. P., de Gruijl, T. D., Parren, P. W. H. I. & van der Vliet, H. J., 21 Mar 2023, In: Cell Reports Medicine. 4, 3, p. 100961 100961.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
Rolfo, C., Giovannetti, E., Martinez, P., McCue, S. & Naing, A., 1 Dec 2023, In: npj Precision Oncology. 7, 1, 26.
Research output: Contribution to journal › Review article › Academic › peer-review

Open Access

Network